Deltabio holds a pioneering position in the genetic medical industry, offering innovative solutions in the healthcare sector and advancing genetic-based medical research. The company utilizes cutting-edge technologies to improve patients' quality of life and combat diseases.

One of Deltabio's key focuses is the development and implementation of genetic tests. These tests analyze individuals' genetic traits to determine predispositions and risk factors for diseases, enabling early diagnosis and prevention. Deltabio supports personalized healthcare services with a wide range of genetic tests, playing a crucial role in assessing patients' health conditions.

Additionally, Deltabio is actively involved in genetic therapy research. Through innovative approaches such as gene therapy, gene editing, and immunotherapy, the company offers effective solutions for treating genetic diseases. These treatments provide a new source of hope for enhancing patients' quality of life and managing diseases.

Deltabio is recognized for its expert team in the industry and its commitment to research and development (R&D) activities. By continuously tracking innovative technologies and treatment methods, the company aims to deliver the best possible service to patients. Continuing its efforts to meet genetic-based healthcare needs and introduce new perspectives in disease management, Deltabio consolidates its leadership position in the industry.